Company intelligence / Profile preview
Shandong Zibo Xinda Pharmaceutical
- Ownership
- Private
- Development stage
- Commercial
Overview
Shandong Zibo Xinda Pharmaceutical is a Chinese pharmaceutical company specializing in the manufacture of generic antibiotics, including cephalosporins and penicillins. Its cefixime capsules have passed China’s generics consistency evaluation, confirming their quality and efficacy equivalence to branded products. The company is a wholly owned subsidiary of Shandong Xinhua Pharmaceutical Company Limited.
- Therapeutic areas
- PulmonologyGastroenterologyNephrologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Shandong Zibo Xinda Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shandong Zibo Xinda Pharmaceutical.